-transparent.png){kind=logo}
OBJECTIVE The role of polymorphonuclear neutrophils (PMN) was examined in local and remote organ injury after intestinal ischemia-reperfusion. BACKGROUND PMN have been found to mediate the local injury in low flow intestinal ischemia-reperfusion. However, in complete intestinal ischemia-reperfusion, prevention of PMN adhesion by monoclonal antibodies to CD11b and CD18 reduces remote but not local intestinal injury. The role of PMN was further investigated in this setting. METHODS In a rat model of 1-hour complete intestinal ischemia and 4-hour reperfusion. PMN were manipulated in the following four ways: (1) inhibition of oxygen-free radicals using manganese superoxide dismutase and catalase (SOD/CAT), (2) antagonism of PMN elastase using secretory leukocyte protease inhibitor (SLPI), (3) neutropenia using PMN antisera, and (4) inhibition of activation and adhesion using interleukin-1 receptor antagonist (IL-1ra) and tumor necrosis factor binding protein (TNFbp). Lung injury was quantified by the pulmonary permeability index, which is the ratio of bronchoalveolar lavage to blood concentration of radiolabeled bovine serum albumin, and PMN sequestration by myeloperoxidase (MPO) activity. Liver injury was estimated by PMN counts using quantitative histologic examination and by serum glutamic pyruvic transaminase (SGPT). Local injury was quantified by MPO activity and histologic grading. RESULTS Neutropenia reduced the pulmonary permeability 80% from 11.0 +/- 0.5 x 10(-3) with saline treatment to 5.50 +/- 0.12 x 10(-3); IL-1ra, to 5.62 +/- 0.44 x 10(-3); and TNFbp, to 4.32 +/- 0.18 x 10(-3) (all p < 0.05). Pulmonary MPO rose from 0.03 +/- 0.01 U/g to 0.25 +/- 0.03 U/g (p < 0.05). This was reduced by neutropenia, 0.01 +/- 0.003 U/g, but not by inhibition of oxygen-free radicals or PMN elastase. IL-1ra inhibited PMN sequestration, reducing MPO to 0.12 +/- 0.01 (p < 0.05). Liver injury was 60% dependent on PMN. Ischemia-reperfusion increased SGPT from 20.3 +/- 0.7 IU/L in the sham-treated animals to 97.0 +/- 3.1 IU/L in the experimental animals. Neutropenia reduced this to 48.1 +/- 3.9 IU/L; IL-1ra, to 44.7 +/- 3.7 IU/L; SOD/CAT, to 64.0 +/- 3.38 IU/L; and SLPI, to 57.1 +/- 3.4 IU/L (p < 0.05 in all cases). Local injury was severe and unaffected by manipulation of the PMN. CONCLUSIONS These data suggest that PMN and their products mediate most of the lung, part of the liver, and none of the local gut injury after intestinal ischemia-reperfusion.
R Simpson, and
R Alon, and
L Kobzik, and
C R Valeri, and
D Shepro, and
H B Hechtman
May 1997,
Journal of applied physiology (Bethesda, Md. : 1985),
R Simpson, and
R Alon, and
L Kobzik, and
C R Valeri, and
D Shepro, and
H B Hechtman
September 1997,
Microcirculation (New York, N.Y. : 1994),
R Simpson, and
R Alon, and
L Kobzik, and
C R Valeri, and
D Shepro, and
H B Hechtman
January 2018,
Biochemical and biophysical research communications,
R Simpson, and
R Alon, and
L Kobzik, and
C R Valeri, and
D Shepro, and
H B Hechtman
February 2022,
Journal of immunology (Baltimore, Md. : 1950),
R Simpson, and
R Alon, and
L Kobzik, and
C R Valeri, and
D Shepro, and
H B Hechtman
August 2006,
Hepatobiliary & pancreatic diseases international : HBPD INT,
R Simpson, and
R Alon, and
L Kobzik, and
C R Valeri, and
D Shepro, and
H B Hechtman
August 1989,
Surgery,
R Simpson, and
R Alon, and
L Kobzik, and
C R Valeri, and
D Shepro, and
H B Hechtman
August 1995,
Shock (Augusta, Ga.),
R Simpson, and
R Alon, and
L Kobzik, and
C R Valeri, and
D Shepro, and
H B Hechtman
January 2023,
International journal of immunopathology and pharmacology,
R Simpson, and
R Alon, and
L Kobzik, and
C R Valeri, and
D Shepro, and
H B Hechtman
September 2003,
Digestive diseases and sciences,
R Simpson, and
R Alon, and
L Kobzik, and
C R Valeri, and
D Shepro, and
H B Hechtman
September 1993,
Critical care medicine,
